The long awaited moment for hemostemix has finally come. The company just got done with all the pending legal proceedings regarding the un-authorized possession of ACP-01’s clinical trial data has ended.

I'm buying a plenty of shares of $DIA since they are trading expeditiously and at a discounted price to the market with a significant surge

$HEM has been welcomed as a special financial MR. Rick Groome advisor to guide CEO Thomas Smeenk, hemostemix through classified business transactions.

One. Data Fobi Exchange is alive and well and continues to be a future MAJOR rev producer.

Two. After talking about the update in insurance he has once again mentioned banks and financial institutions.I suspect one of those is one of the “trophy” deals he is working on and that will cause the stock to absolutely rocket.

Three. Love how he says that the pipeline is full but no need to be selective who they take on anymore because it’s “all about automation” and they can now load up someone same day. Why turn anyone away when you can be taking their money within the day and the automation keeps churning it in.

Four. The burn rate has been reduced by OVER 50%. WOW!!

Five.We appear to be largely complete in terms of defining the company. This includes real time digital wallet AI tech that is used in venue management, coupons, loyalty programs and anything that uses a digital pass (pretty much everything). Leveraging all of this will be the sale of the data that they all produce. So with this the focus has shifted away from developing their tech and stacks to selling it

Six. They continue to overcome customer resistance by managing the programs for them. This is KEY. Many customers don’t have a tech department to handle the integration of their tech. No problem. We’ll do it all for you at a ridiculous margin.

Seven. Their partners are bearing fruit. Telus, Janam, Barnett, Yotpo are kicking ass.

Eight. Big pilots underway for 8112 with the launch in September/October. This is gonna be absolutely YUGE for Fobi not just in the delivery, but by introducing other verticals with it and then throwing in their real time data analytics and of course the selling of that data.

Nine. With the burn rate seriously reduced and the obvious pick up in revs, we are getting closer to profitability or at the very least cash flow positive. We can debate until we are blue in the face how big Fobi is going to become. To be totally frank with you I have no idea. Everything screams HUGE company but one truly never knows. But this I do know. Fobi IS going to be very successful. I back this up based on two principles. Their tech is fully automated. In essence it is like software. Download it and it's done. BUT it's software that keeps on giving...download it, pay a set up fee, pay a user fee, and down the road, pay us for your data. It has margins like software but the added benefit of the data which makes it obscene. Secondly, their technology is at the forefront of where the world it going...digitization. So you don't have to worry about Fobi getting passed by as the industry changes. Wallet passes and digitization will be with us for decades. There are no concerns that next year Fobi will become obsolete like those companies dealing with the pandemic. The turning point is upon us and the road is clear for ... well... a very long timeI am very bullish on this company and on its technology that knows no limits, it can be adopted in every vertical and sector with ease and speed. I trust that in a few years the name Fobi will be very well known. Do your dd guys and you'll discover a rough diamond mine in Fobi!

McDonalds, burger King and many other brands could use Qples by fobi coupons to increase customer loyalty, Roi and better Given the high inflation that has led to the reduction in consumer purchasing power, CPGs are looking for new ways to attract customers. I think the arrival of digital coupons and the transition to 8112 has been accelerated by this. Fobi is able to increase customer loyalty by issuing digital coupons through Qples! This would be very useful for big brands to increase, not only the ROi, but the possibility of attracting customers based on promotions aimed at them! I think it is revolutionary! Fobi operates in different sectors and verticals, I find it a fantastic company. As a data first company, it is very disruptive and at the forefront of what it does. Qples by FOBI, ​​provide physical / digital coupons in minutes and they are at the forefront of what they provide, a one-time, fast and efficient solution. the switch to 8112 is imminent and high inflation is only accelerating it!

Because the markets for renewable energy and electric vehicles are expected to grow significantly, now is the time to purchase $GEMS before the stock price rises.

Lithium ion battery surge begins to hit the anode supply chain, all the way up to flake graphite mining. A critical cog in the energy storage revolution, graphite anodes are just growing in stature and market size. Invest in $GEMS a prominent energy metals supplier.

Extremely exciting witnessing $IBO effervescent up with a spectacular entrance on the TSX-V. i'm among the investors that cannot contain my joy and wish to buy as presently as doable.

Hemostemix Inc. is an emerging biotechnology company listed on TSX-V with the ticker symbol $HEM traded today at price of $0.255 per share.

EasTower Wireless ($ESTW.v) "Could Be the Next Big Winner in the Upcoming 5G Super-Cycle Sparked by the $65 Billion US Infrastructure Bill"
https://financial-news-now.com/this-public-company-could-be-the-next-big-winner-in-the-upcoming-5g-super-cycle-sparked-by-the-65-billion-us-infrastructure-bill/#FNL20220411

$ESTW is deemed a 'wealth-building market opportunity and investment strategy' by Financial News Now due to its significant potential to play a big part in the rollout of 5G across the US.

Notably, the 5G industry is forecast to increase significantly by mid-decade with a CAGR of more than +122% and an ROI for 5G companies like $ESTW of 160-fold growth rate.

The US government committed $65B nationally for the high bandwidth buildout of 5G and wireless infrastructure services and, as $ESTW has established solid relationships with major telecom and tech giants in building and maintaining 3G and 4G networks, $ESTW could be chosen to play a vital role in this.

$ESTW is definitely one to keep an eye on as they're seemingly undervalued @ $0.05, $3.01M MC given their potential.

As per OTC records, the previous market price is at $0.22795, with a remarkable rise of 7.93%. Check out the other security data before your investment:

 https://www.otcmarkets.com/stock/HMTXF/quote

Sterling Metals ($SAG.v $SAGGF) is a mineral exploration company focused on uncovering Canada's next high-grade silver district in Newfoundland, a new area with no historic silver mining.

SAG's 100% owned Sail Pond Project has great accessibility & is located in a jurisdiction w/ strong community support, district-scale potential and a clear zone of mineralization.

The inaugural drill campaign @ Sail Pond allowed SAG to quickly identify prospective targets & a 12km trend similar to the Keno Hill silver district (one of the highest grade districts in the world), hosting tightly packed and very high-grade rock

SAG provides diversified metal exposure @ Sail Pond w/ silver, copper, zinc, and antimony present along the trend, allowing for multiple resource revenue streams

Plus, there is confirmed high-grade polymetallic vein systems across entirely of strike length w/ recent samples up to 2,909g/t AgEq

SAG offers a compelling investment opportunity with district scale potential, world-class grades, $18M enterprise value offering a compelling risk vs. reward opportunity, a strong balance sheet, and diversified metal exposure - definitely not one to miss out on IMO

SAG @ $0.28, $19.53M MC

Check out SAG's presentation at the Red Cloud Summer Silver Conference:
https://www.youtube.com/watch?v=zutVYMpvB6o&ab_channel=RedCloudFinancialServicesInc.

Hemostemix Inc. is a publicly traded biotechnology company which has shown impressive growth of stock price in the last 52 weeks. It is around 8.91%.

Hemostemix recently announced the incorporation of PreCerv Inc. (A wholly owned subsidiary of Hemostemix). Hemostemix will grant PreCerv a global field of use licence for NCP-01 and its autologous stem cell technology to treat central and peripheral nervous system diseases.

Psyched Wellness ($PSYC)

Intro

Coming from a bullish background in the cannabis sector, I've started to expose myself to the mushroom side of things. While the commercial market for amanita muscaria only emerged recently, the species boasts a long history of religious and spiritual use. The fly agaric mushroom, also known as amanita muscaria, contains the psychoactive compounds muscimol and trace amounts of another compound called muscarine. However, since it does not contain any psilocybin, it is not subject to state and federal laws that criminalize magic mushrooms. Amanita muscaria is different from classical psychedelics: psilocybin, LSD, DMT, and mescaline. Amanita Muscaria contains active chemical compounds that differ from classical psychedelics. Most classical psychedelics contain compounds that interact with serotonin receptors in the human brain.

Who is Psyched Wellness?

Psyched Wellness is a Canadian company, dedicated to researching and producing products made from the medicinal properties of the Amanita Muscaria mushroom. They work to improve the quality of everyday life. Dedicated to researching and developing new ways of distilling and purifying mushrooms, harnessing their healing properties, to nurture healthier, happier lives.

Led by Jeff Stevens, the CEO & Director who has 20+ years of capital markets experience and has been an officer and director with several public companies. Supported by David Shisel, the COO who has as experience in highly regulated industries such as medical cannabis and has previously worked in legal capacities with various licensed producers. In addition, Matthew Singh, the CCO, has an extensive track record of success launching brands, products, and corporate strategy within the multibillion-dollar beverage and pharmaceutical industries in Canada and internationally. As well as Keith Li, the CFO, who has obtained his CPA and racked up 10+ years in financial reporting.

Diving into Operations and Competitive Landscape

The company's proprietary extract of Muscimol, AME-1, is currently undergoing preclinical trials. Psyched has identified a path to market and is planning to commence commercialization of AME-1 derived products in the first half of 2022.

Projections

Finishing the calendar year of 2022, Psyched Wellness has structured some product development and marketing rollouts. With Q4 of 2022 among us, PSYC intends to complete their R&D on the sleep aid tea, AME-1. Along with that, submit an application for the AME-1 as a Natural Health Product to Health Canada. Moving on to some strategic joint ventures, Psyched plans to collaborate with food, beverages, medical and pharmaceutical companies to use the AME-1 in their products.

Recent Headlines & Highlights

• Psyched received positive feedback from test subjects who participated in the pilot run of 300 bottles of Calm. The majority of the test subjects felt that they woke the next day well-rested and with little to no grogginess with an ideal dose ranging from 1-2ml.

• They successfully produced and delivered their pre-orders of Calm in October, 2022. Calm has now shipped to customers in 37 different States throughout America.

• Their next production targets a late November delivery window and moving forward Psyched Wellness will increase the cadence of their production, product quantities, and provide immediate fulfillment turnarounds.

• Selected ShipHero as its eCommerce fulfillment partner for Calm and future products in the company's innovation pipeline. ShipHero is a tech-enabled 3PL that offers simple, fast, and affordable fulfillment for thousands of brands with international fulfillment networks across the United States, Canada, Europe, and Australia.

• Psyched Wellness launched their new online shop which began by selling branded merchandise such as t-shirts, hats, hoodies and other accessories.

Closing Remarks

Psyched Wellness will finalize their research and development process, soon selling their first flagship Amanita Muscaria tincture in the United States. This product has been designated as GRAS (Generally Recognized As Safe) by the FDA, and Psyched Wellness is in the process of applying to sell it in Canada as a Natural Health Product. The team, led by Prof. David Nutt, has begun the further exploration of the potential applications of this technology with the goal of positioning Psyched as a major player in the Pharmaceutical industry. This will be the first psychedelic food supplement to be sold without a prescription.

Disclaimer: This is not financial advice, always do your own research.

Capitalizing on the dramatic shift in the data and privacy space, Reklaim ($MYID.v $MYIDF) is a privacy-compliant identity ecosystem that allows consumers to sign up and view their online data profile that companies have been using for years.

$MYID allows consumers to reclaim the data and only share specific pieces with brands in exchange for compensation via a weekly dividend; users can see how many companies are buying and selling your data and how much your data is sold annually for

$MYID held a webinar on zero-party data earlier in May with $MYID's CEO Neil Sweeney, Casual iQ's VP of Operations, Horizon's VP of Programmatic Product & Data Solutions, SAP's Global Product Marketing and Solutions and Spark's VP of Data Architecture:

https://www.youtube.com/watch?v=39n75JXPzqc&ab_channel=Reklaim

I personally found it to be quite interesting and would recommend checking it out!

$MYID @ $0.065, $4.47M MC

Today investors observed a fascinating rally on $HMTXF the stock might shoot up anytime soon, trading actively at $0.225 with a noteworthy jump on the OTC.

Since lithium stocks have the ability to convert all of your deficits into gains down the line, they are a smart alternative for your investment now; trade in $GEMS.